**Core Concept**
Cell wall synthesis is a critical process in bacterial cell growth and division, particularly in Gram-positive bacteria. Inhibiting this process is a common mechanism of action for various antibacterial agents, which target enzymes involved in cell wall formation, such as penicillin-binding proteins (PBPs).

**Why the Correct Answer is Right**
The correct answer will be an antibacterial agent that does not inhibit cell wall synthesis. Other mechanisms of action include inhibiting protein synthesis (e.g., tetracyclines), interfering with DNA replication (e.g., quinolones), or disrupting cell membrane function (e.g., polymyxins). The correct answer will likely be an antibacterial agent that targets one of these alternative mechanisms.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is a beta-lactam antibiotic, which acts by inhibiting cell wall synthesis. Beta-lactams bind to PBPs, preventing the cross-linking of peptidoglycan and ultimately leading to bacterial cell lysis.
* **Option B:** This option is a glycopeptide antibiotic, which also inhibits cell wall synthesis. Glycopeptides bind to PBPs, preventing the incorporation of new peptidoglycan layers into the bacterial cell wall.
* **Option C:** This option is a quinolone antibiotic, which inhibits DNA replication. Quinolones bind to the bacterial DNA gyrase and topoisomerase IV, preventing DNA replication and transcription.

**Clinical Pearl / High-Yield Fact**
When choosing an antibacterial agent, it is essential to understand the target of action and potential resistance mechanisms. Beta-lactam antibiotics, such as penicillins and cephalosporins, are often susceptible to beta-lactamase production, which can be a significant limitation in certain infections.

**Correct Answer:** D.